RECHEM
Welcome to our website!|Hot Line: 86-21-51623867|E-mail: sales@rechemscience.com
Products Category
Contact Us
Tel: +86-21-51623867
  +86-15618786686
Email: sales@rechemscience.com
  info@rechemscience.com
QQ1: 1369748377
Skype: sales@rechemscience.com
Home > Products > Protein Tyrosine Kinase
Cat.No. Product name Product Description
R10003 Infigratinib (Synonyms: BGJ-398; NVP-BGJ398) BGJ398 (NVP-BGJ398) is a potent and selective FGFR inhibitor for FGFR1/2/3 with
R10006 Allitinib tosylate (Synonyms: AST-1306 (TsOH))/897383-62-9 Free base AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM
R10036 XL880; Foretinib; GSK136308 Foretinib (GSK1363089) is an ATP-competitive inhibitor of HGFR and VEGFR, mostly
R10037 ANA12 ANA-12 is a selective TrkB antagonist with Kd of 10 nM and 12 μM for the high an
R10042 CO1686; Rociletinib Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibit
R10054 TAE684 TAE684 (NVP-TAE684) is a potent and selective ALK inhibitor with IC50 of 3 nM in
R10058 Masitinib Masitinib is a novel inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540
R10061 Nexavar; Bay 43-9006; Sorafenib Sorafenib Tosylate is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with I
R10062 SAR131675 SAR131675 is a VEGFR3 inhibitor with IC50/Ki of 23 nM/12 nM in cell-free assays,
R10064 Brivanib; BMS540215 Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, mode
R10076 Crizotinib (PF-02341066) Crizotinib (PF-02341066) is a potent inhibitor of c-Met and ALK with IC50 of 11
R10077 AMG208 AMG 208 is a highly selective c-Met inhibitor with IC50 of 9 nM. Phase 1.
R10078 EMD1214063 Tepotinib (EMD 1214063) is a potent and selective c-Met inhibitor with IC50 of 4
R10087 AZD9291 Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
R10118 Regorafenib; BAY73-4506; BAY734506 Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3
R10126 WZ4002 WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with
R10127 Linifanib (Synonyms: ABT-869; AL-39324) Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for
R10138 Tivozanib;AV-951; KRN951 Tivozanib (AV-951) is a potent and selective VEGFR inhibitor for VEGFR1/2/3 with
R10143 Cabozantinib (XL184; BMS-907351) Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035
R10150 Ceritinib; LKD378 Ceritinib (LDK378) is potent inhibitor against ALK with IC50 of 0.2 nM in cell-f
R10151 E7080; Lenvatinib Lenvatinib (E7080) is a multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Fl
R10152 Neratinib; HKI272 Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5
R10156 Nintedanib; BIBF1120 Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3,
R10192 ZM323881HCl ZM 323881 is a potent and selective VEGFR2 inhibitor with IC50 of <2 nM, almo
R10193 ZM 306416 (Synonyms: CB 676475) ZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, bu
Page 1 / Total 4 FirstPrevNextLastGoto
<button id="kwhys"><acronym id="kwhys"></acronym></button>

<dd id="kwhys"></dd>
<button id="kwhys"></button>
      1. <progress id="kwhys"></progress>
        <tbody id="kwhys"><track id="kwhys"></track></tbody>
        <em id="kwhys"><tr id="kwhys"></tr></em>